approved

Приложение 4 на ПЛС от 02.06.2019 г.

Unique identificator:  f09a5d85-659a-4b8f-bb62-2e369d2147cb

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-06-04 09:40:33
  • Created by: georgi_sivchev
  • Updated at: 2019-06-04 09:40:33
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Somatostatin II-14278/27.09.2006 SOMATOSTATIN LYOMARK, Powder for solution for injection/infusion, 3, mg, Pack: 5 Lyomark Pharma GmbH, Германия Wasserburger Arzneimittelwerk GmbH, Germany 567.19 113.44 680.63 4% 10 577.19 115.44 692.63 16% 25 602.19 120.44 722.63 Протокол №242/14.09.2017 КЦ-1152/07.10.2009 29.10.2009 02.10.2017 Активен 832
Somatostatin II-14278/27.09.2006 SOMATOSTATIN LYOMARK, Powder and solvent for solution for injection, 3, mg, Pack: 1 Lyomark Pharma GmbH, Германия Wasserburger Arzneimittelwerk GmbH, Germany 131.04 26.21 157.25 4% 5.24 136.28 27.26 163.54 16% 20.97 157.25 31.45 188.7 Прот. № 217/30.03.2017 КЦ-1152/07.10.2009 29.10.2009 02.04.2017 Активен 831
Somatostatin II-14278/27.09.2006 SOMATOSTATIN LYOMARK 3, Powder and solvent for solution for injection, 3, mg, Pack: 5 Lyomark Pharma GmbH, Германия Wasserburger Arzneimittelwerk GmbH, Germany 567.19 113.44 680.63 4% 10 577.19 115.44 692.63 16% 25 602.19 120.44 722.63 КЦ-1152/07.10.2009 29.10.2009 29.10.2009 Неактивен 832
Somatostatin II-14278/27.09.2006 SOMATOSTATIN LYOMARK 3, Powder and solvent for solution for injection, 3, mg, Pack: 1 Lyomark Pharma GmbH, Германия Wasserburger Arzneimittelwerk GmbH, Germany 131.04 26.21 157.25 4% 5.24 136.28 27.26 163.54 16% 20.97 157.25 31.45 188.7 КЦ-1152/07.10.2009 29.10.2009 29.10.2009 Неактивен 831
Somatostatin 20120385 Somatostatin PH&T, Powder and solvent for solution for injection, 3, mg, Pack: 1 флакон + 1 ампула PH & T S.p.A., Италия Alfa Wassermann S.p.A., Италия 93.96 18.79 112.75 4% 3.76 97.72 19.54 117.26 16% 15.03 112.75 22.55 135.3 НСР-4635/15.09.2014; НСР-13233/17.07.2017 30.09.2014 02.09.2017 Заличен 3172
Somatostatin 20120385 Somatostatin PH&T, Powder and solvent for solution for injection, 3, mg, Pack: 1 флакон + 1 ампула PH & T S.p.A., Италия Alfa Wassermann S.p.A., Италия 93.96 18.79 112.75 4% 3.76 97.72 19.54 117.26 16% 15.03 112.75 22.55 135.3 НСР-4635/15.09.2014 30.09.2014 30.09.2014 Неактивен 3172
Somatostatin II-0860/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 44.53 8.91 53.44 4% 1.78 46.31 9.26 55.57 16% 7.12 53.43 10.69 64.12 КЦРР-1205/13.08.2012 г;; НСР-12049/21.03.2017 28.12.2012 02.05.2017 Заличен 1498
Somatostatin II-0860/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 44.53 8.91 53.44 4% 1.78 46.31 9.26 55.57 16% 7.12 53.43 10.69 64.12 КЦРР-1205/13.08.2012 г 28.12.2012 28.12.2012 Неактивен 1498
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 3.72 0.74 4.46 7% 0.26 3.98 0.8 4.78 20% 0.74 4.72 0.94 5.66 НСР-5738/26.02.2015.; НСР-12049/21.03.2017 12.03.2015 02.05.2017 Заличен 3635
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 3.72 0.74 4.46 7% 0.26 3.98 0.8 4.78 20% 0.74 4.72 0.94 5.66 НСР-5738/26.02.2015. 12.03.2015 12.03.2015 Неактивен 3635
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 3.91 0.78 4.69 7% 0.27 4.18 0.84 5.02 20% 0.78 4.96 0.99 5.95 КЦРР-1205/13.08.2012 г 28.12.2012 28.12.2012 Неактивен 3635
Somatostatin II-0860/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 89.58 17.92 107.5 4% 3.58 93.16 18.63 111.79 16% 14.33 107.49 21.5 128.99 КЦ-673/06.03.2009 24.03.2009 24.03.2009 Неактивен 1498
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 18.66 3.73 22.39 6% 1.12 19.78 3.96 23.74 18% 3.36 23.14 4.63 27.77 КЦ-673/06.03.2009 24.03.2009 24.03.2009 Неактивен 3635
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 3238.78 647.76 3886.54 4% 10 3248.78 649.76 3898.54 16% 25 3273.78 654.76 3928.54 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8981/14.04.2016.; НСР-17510/13.12.2018 28.12.2018 02.01.2019 Активен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8981/14.04.2016. 30.04.2016 02.12.2018 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 Протокол №242/14.09.2017 НСР-8981/14.04.2016. 30.04.2016 02.10.2017 Неактивен 3300
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение 25.06.2018 02.12.2018 Активен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение 25.06.2018 02.08.2018 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение* 25.06.2018 02.07.2018 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4880.58 976.12 5856.7 4% 10 4890.58 978.12 5868.7 16% 25 4915.58 983.12 5898.7 Протокол №242/14.09.2017 НСР-8982/14.04.2016. 30.04.2016 02.10.2017 Неактивен 3301
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 6919.96 1383.99 8303.95 4% 10 6929.96 1385.99 8315.95 16% 25 6954.96 1390.99 8345.95 цената се заличава КЦРР-2538/14.03.2013 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Заличен 1643
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 7132.23 1426.45 8558.68 4% 10 7142.23 1428.45 8570.68 16% 25 7167.23 1433.45 8600.68 изготвено корекционно решение КЦ-670/06.03.2009 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 1643
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4880.58 976.12 5856.7 4% 10 4890.58 978.12 5868.7 16% 25 4915.58 983.12 5898.7 НСР-8982/14.04.2016. 30.04.2016 30.04.2016 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4902.09 980.42 5882.51 4% 10 4912.09 982.42 5894.51 16% 25 4937.09 987.42 5924.51 Прот. № 136/16.09.2015 НСР-6850/30.07.2015 14.08.2015 14.08.2015 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5062.69 1012.54 6075.23 4% 10 5072.69 1014.54 6087.23 16% 25 5097.69 1019.54 6117.23 НСР-4867/17.10.2014 03.11.2014 03.11.2014 Неактивен 3301
Showing 12026 to 12051 of 14923 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте